The trademark application AAGYLUR was filed by Cycle Pharmaceuticals Ltd, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on September 7, 2023, and it was registered by office on December 15, 2023 without any oppositions.
The application was filed in English (French was selected as the second language).